🇺🇸 FDA
Patent

US 7202040

Method for screening compounds which change the binding properties of a protein with a ligand

granted A61KA61K31/00A61P

Quick answer

US patent 7202040 (Method for screening compounds which change the binding properties of a protein with a ligand) held by Takeda Pharmaceutical Company Limited expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/00, A61P, A61P25/00, A61P29/00